JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study

  • 0Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Dalian Medical University), Shenyang, China.
Expert Review of Gastroenterology & Hepatology +

|

February 16, 2024

|

February 16, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A new modified Liaoning score improves long-term outcome prediction in liver cirrhosis patients. This enhanced score combines clinical and lab data for better accuracy than existing models.

Area Of Science

  • Hepatology
  • Clinical Medicine
  • Prognostic Modeling

Background

  • The Liaoning score is established for predicting esophageal varices in liver cirrhosis.
  • Liver cirrhosis poses significant long-term outcome risks for patients.
  • Accurate prognostic tools are crucial for managing cirrhotic patients.

Purpose Of The Study

  • To modify the existing Liaoning score by incorporating clinical and laboratory parameters.
  • To develop a novel prognostic model for predicting the long-term survival of cirrhotic patients.
  • To validate the performance of the modified Liaoning score against established scoring systems.

Main Methods

  • Retrospective enrollment of 474 cirrhotic patients in China for training.
  • Identification of independent predictors of mortality using competing risk analyses.
  • External validation of the modified Liaoning score across three international centers (China and Brazil).

Main Results

  • Age, total bilirubin, albumin, serum creatinine, and the original Liaoning score were significant predictors of death.
  • The modified Liaoning score demonstrated superior predictive performance (AUC=0.714) compared to Child-Pugh, MELD, and the original Liaoning score.
  • A modified Liaoning score threshold (≥1.296) indicated a significantly higher cumulative incidence of death in liver cirrhosis patients.
  • The modified score maintained high prognostic accuracy in independent validation cohorts from China and Brazil.

Conclusions

  • The modified Liaoning score offers a more accurate prediction of long-term outcomes in liver cirrhosis.
  • This enhanced score can aid clinicians in risk stratification and patient management.
  • Further clinical consideration of the modified Liaoning score is warranted for cirrhotic patients.

Keywords: